Pacific Biosciences of California Inc reports results for the quarter ended in June - Earnings Summary

Pacific Biosciences of California

02/08/2023 22:58

* Pacific Biosciences of California Inc  PACB.OQ  reported a
quarterly adjusted loss of 28 cents​​ per share for the quarter
ended in June. The mean expectation of eleven analysts for the
quarter was for a loss of 32 cents per share.
    * Revenue rose 34.1% to $47.57 million from a year ago;
analysts
expected $40.30 million. 
    * Pacific Biosciences of California Inc's reported EPS for
the
quarter was a loss of 28 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Pacific Biosciences of California Inc shares had risen
by 0.3%
this quarter and gained 63.1% so far this year.
    * The company reported a quarterly loss of $69.83 million.
    * Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 09:57 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.32          -0.28          Beat
 Mar. 31 2023      -0.33          -0.36          Missed
 Dec. 31 2022      -0.36          -0.37          Missed
 Sep. 30 2022      -0.33          -0.34          Missed